Source: MarketScreener

LogicBio: LOGC FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL LAWYERS, Reminds LogicBio Investors of Important Deadline in Securities Class Action - LOGC

( NEW YORK, May 18, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of LogicBio Therapeutics, Inc. between December 3, 2018 and February 10, 2020, inclusive of the important May 18, 2020 lead plaintiff deadline in the class action first filed by the firm. The lawsuit seeks to...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Frederic Chereau's photo - President & CEO of LogicBio

President & CEO

Frederic Chereau

CEO Approval Rating


LogicBio is a biotechnology company that develops genetic medicines to treat rare pediatric diseases. Read more